The 2008 American College of Rheumatology Recommendations for the Use of Nonbiologic and Biologic Disease-Modifying Antirheumatic Drugs in Rheumatoid Arthritis: Where the Rubber Meets the Road.

The article reflects on the recommendations of the American College of Rheumatology (ACR) on the use of nonbiologic and biologic disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis (RA). It discusses a study conducted by K. G. Saag and colleagues which focused on the indications for use of these drugs, its side effects, and the role of cost and patient preferences in decision making.